Within six days of receiving a second injection of Pfizer’s experimental Wuhan coronavirus (Covid-19) vaccine, a two-year-old baby enrolled in the company’s clinical trials for children passed away, new reports indicate.
The ongoing trials include more than 10,000 children aging in range from five to 11 in one of the groups, and another 10,000 children as young as six months old in the other. These trials have been taking place since mid-March with the soon expectation that the jab will be “authorized” for use in children and babies.
